2015 FWP Euro Offering





Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-186979
Dated May 26, 2015



Eli Lilly and Company

Pricing Term Sheet
1.000% Notes due 2022
1.625% Notes due 2026
2.125% Notes due 2030
Issuer:
Eli Lilly and Company
 
 
 
 
Principal Amount:
€600,000,000
€750,000,000
€750,000,000
 
 
 
 
Maturity Date:
June 2, 2022
June 2, 2026
June 3, 2030
 
 
 
 
Coupon:
1.000% per year
1.625% per year
2.125% per year
 
 
 
 
Public Offering Price:
99.617% of principal amount
99.541% of principal amount
98.473% of principal amount
 
 
 
 
Yield to Maturity:
1.057%
1.671%
2.246%
 
 
 
 
Benchmark Bund:
DBR 2.000% due January 4, 2022
DBR 0.500% due February 15, 2025
DBR 4.750% due July 4, 2028
 
 
 
 
Spread to Benchmark Bund:
+86.3 bps
+112.7 bps
+149.3 bps
 
 
 
 
Benchmark Bund Yield / Price:
0.194% / 111.84
0.544% / 99.58
0.753% / 149.68
 
 
 
 
Spread to Mid Swaps:
+45 bps
+70 bps
+107 bps
 
 
 
 
Mid Swaps Yield:
0.607%
0.971%
1.176%
 
 
 
 
Interest Payment Dates:
Annually on June 2, commencing
June 2, 2016
Annually on June 2, commencing
June 2, 2016
Annually on June 3, commencing
June 3, 2016
 
 
 
 
Redemption Provisions:
 
 
 
Make-whole call:
Prior to March 2, 2022,
make whole plus 15 bps,
plus accrued and unpaid interest, if any
Prior to March 2, 2026,
make whole plus 20 bps,
plus accrued and unpaid interest, if any
Prior to March 3, 2030,
make whole plus 25 bps,
plus accrued and unpaid interest, if any
Par call:
On or after March 2, 2022, at 100%, plus accrued and unpaid interest, if any
On or after March 2, 2026, at 100%, plus accrued and unpaid interest, if any
On or after March 3, 2030, at 100%, plus accrued and unpaid interest, if any
 
 
 
 




Underwriting Discounts:
0.400%
0.475%
0.550%
 
 
 
 
CUSIP / ISIN / Common Code:
532457 BL1 /
XS1240750767 /
124075076
532457 BM9 /
XS1240751062 /
124075106
532457 BN7 /
XS1240751229 /
124075122
 
 
 
 
Trade Date:
May 26, 2015
 
 
 
 
Settlement Date:
June 2, 2015 (T+5)
 
 
 
 
Expected Ratings*:
Moody’s: A2 (Stable); Standard & Poor’s: AA- (Stable)
 
 
 
Denominations:
€100,000 and integral multiples of €1,000 in excess thereof
 
 
 
 
Day Count:
Actual / Actual (ICMA)
 
 
 
Offering Format:
SEC Registered
 
 
 
Listing:
Application will be made to list the notes on the New York Stock Exchange
 
 
 
Joint Book-Running Managers:
Credit Suisse Securities (Europe) Limited, Deutsche Bank AG, London Branch, J.P. Morgan Securities plc, Morgan Stanley & Co. International plc and UBS Limited
 
 
 
 
Co-Managers:
Barclays Bank PLC and Drexel Hamilton, LLC
 
*Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Credit Suisse Securities (Europe) Limited toll-free at 1-800-221-1037, Deutsche Bank AG, London Branch toll-free at 1-800-503-4611 and J.P. Morgan Securities plc collect at +44-207-134-2468.